Post

Conversation

This vial contains a new drug called PAC-3310. It was designed by ChatGPT, and I synthesized it in a chemistry lab I built in my garage. PAC-3310 is a new selective M4 muscarinic receptor agonist for treating schizophrenia - similar to the recent breakthrough drug Cobenfry, but improved. (1/7)
David Watson 🥑
Post your reply

1 in 4 people with schizophrenia don’t respond to any existing drugs/treatments. In 2024, Cobenfry made waves by becoming the first FDA-approved schizophrenia drug with a totally new mechanism. Rather than blocking dopamine receptors like all previous schizophrenia drugs, it
Image
An alternative, more direct strategy that avoids the side effects of Cobenfry altogether is to design the muscarinic agonist to be ‘subtype-specific’ - that is, activate only M4, and not any of the other muscarinic receptors. This is exactly what PAC-3310 does. (3/7)
My new drug PAC-3310 improves on Cobenfry by exhibiting a much better selectivity profile across the five muscarinic receptors. In functional cell assays, PAC-3310 has nanomolar potency for M4 (EC50 = 97 nM) and >100x selectivity over M1, M2, M3, and M5 (EC50 > 10 uM for each).
When administered to mice, PAC-3310 significantly reduces MK-801-induced hyperlocomotion, demonstrating that it has antipsychotic effects in vivo. Moreover, at doses up to 10x the effective dose, PAC-3310 produces none of the side effects typical of non-selective muscarinic
The media could not be played.
Finally, PAC-3310 exhibits excellent pharmacokinetics (oral bioavailability > 70%, brain/plasma ratio > 0.5, plasma protein binding < 80%) and manufacturability. (6/7)
Image
PAC-3310 is the second drug to come out of my AI-enabled home drug discovery lab, the first being PAC-832 for Alzheimer’s disease which I announced 2 months ago (x.com/DouglasYaoDY/s). I heavily utilized frontier AI models and liquid-handling robotics to develop both drugs.
Quote
Douglas Yao
@DouglasYaoDY
This vial contains a new drug called PAC-832, which I recently invented to treat Alzheimer’s disease. It is the world’s first selective GalR1 antagonist. I designed and synthesized PAC-832 in a chemistry lab I built in my garage. (1/16)
Stop focusing on pointless things like schizophrenia and please lock in on Male Pattern Baldness
> was designed by ChatGPT > chemistry lab I built in my garage hmm > treating schizophrenia ah.
Believing you single-handedly cured schizophrenia on a commercial laundry folding table in a garage is, ironically, a classic symptom of schizophrenia.
You should ingest it, on video, and document your body’s reactions. Prove to us that AI is actually useful. Come on Douglas, don’t be scared, put the ChatGPT research chemical in your mouth, on video.
Very cool and interesting. Can you create one that induces schizophrenia? Asking for a non-government associated friend.
How tf do you get past guardrails that would prevent this unless you were using a non-frontier model that’s just as schizophrenic as the person who would take this? 😭